Skip to search.
 TSX Up 0.53% TSX Ventures Up 0.55%

Transition Therapeutics Inc. (TTHI)

-NasdaqGM
2.21 Up 0.03(1.38%) 3:31PM EDT - Nasdaq Real Time Price
Add to Portfolio
Prev Close:2.18
Open:2.17
Bid:2.20 x 100
Ask:2.21 x 100
1y Target Est:4.50
Beta:2.07
Next Earnings Date:N/A
Day's Range:2.10 - 2.22
52wk Range:1.95 - 9.30
Volume:53,304
Avg Vol (3m):175,444
Market Cap:81.52M
P/E (ttm):N/A
EPS (ttm):-1.11
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
TTHIUp 1.38%81.52M
GSKDown 0.41%104.84B
MRKUp 0.56%166.26B
PFEUp 0.98%222.17B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-15) :-1.34
Quarterly EPS Est (Jun-15) :-0.25
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Transition Therapeutics Inc., a biopharmaceutical company, researches and develops therapeutic agents for disease indications in Canada. The company's lead central nervous system drug candidate is ELND005, a Phase II clinical trial product us... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback